Heart, Lung and Circulation最新文献_第5页

The Use of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting Transcatheter Aortic Valve Implantation Mortality. 使用中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值预测经导管主动脉瓣植入术死亡率。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-08 DOI: 10.1016/j.hlc.2024.07.006

Sachin Nair, Francis J Ha, Arul Baradi, Shane Nanayakkara, Lucy Soden, David Jin, Robert Whitbourn, Andrew Wilson, Sonny Palmer

{"title":"The Use of the Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Predicting Transcatheter Aortic Valve Implantation Mortality.","authors":"Sachin Nair, Francis J Ha, Arul Baradi, Shane Nanayakkara, Lucy Soden, David Jin, Robert Whitbourn, Andrew Wilson, Sonny Palmer","doi":"10.1016/j.hlc.2024.07.006","DOIUrl":"10.1016/j.hlc.2024.07.006","url":null,"abstract":"Aim: Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are simple biomarkers that reflect systemic inflammation and are associated with adverse cardiovascular disease outcomes. The utility of NLR and PLR for risk prediction following transcatheter aortic valve implantation (TAVI) is not clear.Method: We retrospectively analysed a prospectively maintained database of patients who underwent TAVI at a tertiary hospital from 2009 to 2022. Baseline demographics, NLR, PLR and Society of Thoracic Surgeons Predicted Risk of Mortality (STS-PROM) scores were obtained. The 30-day and 1-year survival rates were analysed using a logistic regression model while overall survival was analysed using the Kaplan-Meier method. Predictors of survival were calculated using a Cox-hazards regression model and presented as odds ratio (OR) with 95% confidence interval (CI).Results: Overall, 367 patients were included in this study (mean age 84 years, 51% male). Median follow-up was 19 months (interquartile range 8.8-40 months) with a median survival of 7.2 years (interquartile range 3.5-10.3 years). NLR was associated with 30-day mortality (OR 1.75; 95% CI 1.25-2.68; p<0.01). PLRs marginally predicted 1-year mortality (OR 1.01; 95% CI 1.00-1.02). However, only the STS-PROM score significantly predicted overall survival (hazard ratio 1.07; 95% CI 1.02-1.12; p=0.03) after adjustment for NLR and PLR.Conclusions: NLR is associated with 30-day mortality following TAVI. PLR was not a clinically significant predictor of mortality after TAVI. Only the STS-PROM score remained a significant predictor of overall survival.","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":" ","pages":"1680-1687"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Transcatheter Aortic Valve Implantation Failure: Critique and Future Directions. 经导管主动脉瓣植入失败：批评与未来方向。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 DOI: 10.1016/j.hlc.2024.09.005

Mohammad Sarraf, Vinayak Nagaraja

引用次数: 0

Multiple Pulmonary Arteriovenous Malformations in a Cyanotic Child. 一名青紫儿童的多发性肺动静脉畸形

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-10 DOI: 10.1016/j.hlc.2024.04.312

Ertugrul Cakir, Serdar Aslan, Gokhan Tonkaz

引用次数: 0

Trends in Sudden Unexpected Deaths in an Australian Population: Impact of the COVID-19 Pandemic. 澳大利亚人口的意外猝死趋势：COVID-19 大流行的影响。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-10 DOI: 10.1016/j.hlc.2024.07.009

James Healy, Andrew M Youssef, Sonia Sawant, Jessica J Orchard, Rajan Rehan, Rianie Van Vuuren, John W Orchard, Christopher Semsarian, Rajesh Puranik

{"title":"Trends in Sudden Unexpected Deaths in an Australian Population: Impact of the COVID-19 Pandemic.","authors":"James Healy, Andrew M Youssef, Sonia Sawant, Jessica J Orchard, Rajan Rehan, Rianie Van Vuuren, John W Orchard, Christopher Semsarian, Rajesh Puranik","doi":"10.1016/j.hlc.2024.07.009","DOIUrl":"10.1016/j.hlc.2024.07.009","url":null,"abstract":"Background & aim: SARS-CoV-2 infection is associated with increased cardiovascular (CV) morbidity and mortality, manifesting as increased adverse outcomes in the first 30 days, extending to 12 months. This study aimed to investigate trends in sudden unexpected deaths between 2018 and 2022, with a focus on CV deaths.Method: A retrospective analysis was performed on autopsy reports (n=9,330) obtained from New South Wales Coroners Court, Australia, specifically targeting cases of unexplained deaths that occurred between 2018 and 2022. Statistical analysis was conducted using chi-square tests and a post hoc analysis with Bonferroni correction, as well as analysis of variance with multiple comparisons.Results: There were 349 (18.3%) CV deaths in 2018, 346 (18.0%) in 2019, 338 (17.5%) in 2020, 395 (21.9%) in 2021, and (23.4%) 413 in 2022 (p=0.0002). Among CV deaths, the number of deaths from sudden arrhythmic death syndrome were 25 (7.2%) in 2018, 26 (7.5%) in 2019, 18 (5.3%) in 2020, 52 (13.2%) in 2021, and 80 (19.4%) in 2022 (p=0.0001). Atherosclerosis was the most common cause of death among all CV categories; there were 196 (56.2%) atherosclerosis deaths in 2018, 207 (59.8%) in 2019, 192 (56.8%) in 2020, 221 (56.0%) in 2021, and 197 (47.7%) in 2022 (p=0.43). The average age of death from sudden arrhythmic death syndrome (42.8±19.1 years) across 2018-2022 was younger than atherosclerosis (56.2±12.4 years) and total groups (53.1±15.1 years) (p<0.001). Males comprised 76% of all CV deaths from 2018 to 2022 (p<0.0001).Conclusions: Compared with pre-pandemic data, a noteworthy increase in CV deaths was observed in occurrence with the escalation in COVID-19 cases in Australia. This may be attributed to direct or indirect factors, such as lifestyle modifications, disrupted access to routine cardiac care, or COVID-19 infection-triggered CV deaths.","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":" ","pages":"1693-1698"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Multimodality Imaging Evaluation of Tumour Peeking Its Head Into the Right Atrium. 肿瘤头部探入右心房的多模态成像评估

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-23 DOI: 10.1016/j.hlc.2024.06.1039

Kouta Nakamura, Akinobu Miyazaki, Masahiro Suzuki, Ken-Ichi Imasaka, Kisho Ohtani

引用次数: 0

Reply to Letter to the Editor "Addressing Gaps in Post-MI Medication Use Study" regarding: "Patterns of 12-Month Post-Myocardial Infarction Medication Use According to Revascularisation Strategy: Analysis of 15,339 Admissions in Victoria, Australia". 回复致编辑的信 "弥补心肌梗死后用药研究的不足"，内容涉及"心肌梗塞后 12 个月用药模式取决于血管重建策略：对澳大利亚维多利亚州 15,339 例入院患者的分析"。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 DOI: 10.1016/j.hlc.2024.10.007

Adam C Livori, Zanfina Ademi, Jenni Ilomäki, Adam J Nelson, J Simon Bell, Jedidiah I Morton

引用次数: 0

Knowledge of Acute Coronary Syndrome Symptoms and the Intention to Call Emergency Medical Services in Culturally and Linguistically Diverse Australians. 具有不同文化和语言背景的澳大利亚人对急性冠状动脉综合征症状的了解以及拨打紧急医疗服务电话的意愿。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-10 DOI: 10.1016/j.hlc.2024.07.008

Ararso Baru Olani, Kathryn Eastwood, Stuart Howell, Amanda Buttery, Janet E Bray

{"title":"Knowledge of Acute Coronary Syndrome Symptoms and the Intention to Call Emergency Medical Services in Culturally and Linguistically Diverse Australians.","authors":"Ararso Baru Olani, Kathryn Eastwood, Stuart Howell, Amanda Buttery, Janet E Bray","doi":"10.1016/j.hlc.2024.07.008","DOIUrl":"10.1016/j.hlc.2024.07.008","url":null,"abstract":"Background: Prompt recognition of symptoms and response to acute coronary syndrome (ACS) are crucial for reducing pre-hospital delay. This study compares culturally and linguistically diverse (CALD) and non-CALD Australian populations in terms of their (i) ACS symptom knowledge and (ii) intention to call emergency medical services (EMS) for ACS.Method: This cross-sectional study used data from HeartWatch, an online survey collected by the National Heart Foundation of Australia between 2018 and 2020 for Australian adults aged ≥18 years. CALD respondents were defined as non-Indigenous individuals who reported speaking a language other than English at home. Characteristics associated with ACS symptom knowledge and EMS calling intentions were analysed using multivariable logistic regression.Results: Of 31,919 respondents, 16.3% were from CALD backgrounds (n=5,212). Compared with non-CALD, CALD respondents were less likely to name any ACS symptom (63.0% vs 76.0%; adjusted odds ratio [AOR] 0.66; 95% confidence interval [CI] 0.61-0.70) and were less likely to state that they would call an ambulance for ACS (50.2% vs 72.1%; AOR 0.53; 95% CI 0.50-0.57). Almost one-quarter (23.0%) of CALD respondents reported not knowing what they would do. In both groups, males, individuals aged ≤60 years, and those with diabetes were less likely to name an ACS symptom and had lower intention to call an ambulance. Those unable to list a single ACS symptom also had a lower intention to call an ambulance.Conclusions: Knowledge of ACS symptoms and intention to call an ambulance were lower among CALD respondents. The demographics of those with low ACS symptom knowledge and EMS calling intention were similar in the two groups. Future education efforts in Australia should focus on promoting ACS symptom knowledge and EMS use and should target these groups.","PeriodicalId":13000,"journal":{"name":"Heart, Lung and Circulation","volume":" ","pages":"1659-1669"},"PeriodicalIF":2.2,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142400177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Atrial Fibrillation is an Important String to our Surgical Bow: Lets do More! 心房颤动是我们外科弓的重要一环：让我们做得更多！

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 DOI: 10.1016/j.hlc.2024.11.004

Jaishankar Raman, John Alvarez

引用次数: 0

Perforation of the Septal Perforators: A Case Series and Proposed Management Paradigm. 房间隔穿孔：一个病例系列和拟议的治疗范例。

IF 2.2 4区医学

Heart, Lung and Circulation Pub Date : 2024-12-01 Epub Date: 2024-10-23 DOI: 10.1016/j.hlc.2024.09.006

Daniel G Brieger, Aditya Bhat, Ravinay Bhindi, Michael R Ward

引用次数: 0

Retraction notice: Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study: [Heart, Lung and Circulation, Volume 29, Issue 7, July 2020, Pages e131-e139]. 撤回通知：心房颤动患者心脏药物依从性：一项试点研究：[心脏，肺和循环，第29卷，第7期，2020年7月，页e131-e139]。